Morning Market Gainers

jumped 13.16 percent to $17.71 after the company reported upbeat results for its fiscal second quarter.

shares rose 12.39 percent to $3.90. JMP Securities initiated coverage on Carbylan Therapeutics with a Market Perform rating and a $13.00 price target.

shares climbed 8.28 percent to $23.29. Lawson Products is expected to report its Q3 results on October 22, 2015.

shares gained 6.80 percent to $55.23 following a Bloomberg report that 'China may give economic support'. In September, gambling revenue in Macau dropped 33 percent year-over-year.

shares jumped 4.89 percent to $3.65 after the company announced plans to focus on HORIZANT business and named Vincent Angotti as CEO. XenoPort will discontinue the development of XP23829 and seek to partner this and other high potential development stage assets

rose 3.25 percent to $15.25 after the company reported better-than-expected earnings for its fiscal fourth quarter.